skip to main content

Listen

Read

Watch

Schedules

Programs

Events

Give

Account

Donation Heart Ribbon

Science

Despite Rise Of ISIS, Isis Pharmaceuticals Will Keep Its Name

Sept. 4
By David Wagner
Tease photo

The rise of ISIS has triggered some rebranding efforts among organizations unlucky enough to share a name with the terrorist group. But one Carlsbad-based drug company is holding off on a name change.

San Diego Biotech Lands Up To $42 Million For Ebola Drug Development

Sept. 2
By David Wagner
Tease photo

A U.S. health agency has awarded San Diego-based Mapp Biopharmaceutical new funding to speed up work on an experimental Ebola drug.

Climate Change Could Soak Up California's Fresh Mountain Water Runoff

Sept. 1
By David Wagner
Tease photo

A new study suggests rising temperatures could cut into California's water supply.

San Diego Company Opens Up About Experimental Ebola Drug

Aug. 27
By David Wagner
Tease photo

After weeks of shying away from the news media, the head of a small San Diego drug company finally talked publicly about his company's experimental Ebola treatment ZMapp.

African Doctor Treated With San Diego Company's Ebola Drug Dies

Aug. 25
By David Wagner
Tease photo

A Liberian doctor's death is the second among the six people treated with ZMapp, an experimental drug to treat Ebola made by a San Diego-based biotech.

76-Mile Relay Swim Canceled After Shark Encounters

Aug. 25
By City News Service
Tease photo

The relay swim from Catalina Island to La Jolla Cove was in support of wounded veterans.

63 Trillion Gallons Of Water Lost In Drought-Ridden West, Study Finds

Aug. 22
By Susan Murphy
Tease photo

Trillions of gallons of water across the western United States have been lost due to the severe drought, according to a new study. The shrinking water supply has caused the earth to rise.

Sheriff’s Department Not Ready To Embrace Crime-Fighting Website

Aug. 21
By Claire Trageser
Tease photo

A website called Nextdoor.com is partnering with San Diego law enforcement agencies — with one notable exception — to allow officers to post information and get private messages from residents.

Judging An Ebola Drug In The Middle Of A Crisis

Aug. 21
By David Wagner
Tease photo

In most cases, Ebola is a death sentence. But most of the infected patients who've taken a San Diego company's experimental drug have lived. Does that mean it works?

San Diego's Sanford-Burnham Institute Gets New Chief

Aug. 19
By Erik Anderson
Tease photo

An oncologist who spent part of his career in the pharmaceutical world is the new chief executive officer at the Sanford-Burnham Medical Research Institute.